https://geneticliteracyproject.org/2026/08/25/the-story-behind-modernas-cancer-vaccine-miracle/
A personalized mRNA shot for melanoma just did something no cancer vaccine has done before. As The Wall Street Journal’s Alex Janin reports, the company’s personalized mRNA cancer vaccine, intismeran autogene, succeeded in a Phase 3 trial for high-risk melanoma patients — the first personalized mRNA cancer therapy to hit its mark in a late-stage study.
No hay comentarios:
Publicar un comentario